Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Bragar Eagel & Squire, P.C. Is Investigating Cantaloupe, Compass, and Spectrum and Encourages Investors to Contact the Firm

October 02, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗

October 02, 2022

Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...

Via Benzinga

SPECTRUM ALERT: Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, Inc. on Behalf of Spectrum Stockholders and Encourages Investors to Contact the Firm

September 29, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst ↗

September 23, 2022

Via Benzinga

After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding ↗

September 23, 2022

Via Benzinga

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗

September 26, 2022

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Via Benzinga

FDA's Adcomm Gives Thumbs Down To Spectrum Pharmaceuticals' Lung Cancer Candidate ↗

September 23, 2022

Via Benzinga

Dow Hits New 2022 Low; Gold Falls Sharply ↗

September 23, 2022

U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping to a fresh low for the year.

Via Benzinga

Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗

September 23, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day...

Via Benzinga

Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply ↗

September 23, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.

Via Benzinga

11 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 23, 2022

Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 23, 2022

We're breaking down the biggest pre-market stock movers for Friday morning alongside the news that traders need to know about!

Via InvestorPlace

Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket ↗

September 23, 2022

Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading.

Via Benzinga

Spectrum Pharmaceuticals Announces Debt Financing Agreement with SLR Capital Partners with $30 Million Funded at Closing

September 23, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 22, 2022

Gainers Genfit (NASDAQ:GNFT) shares increased by 27.4% to $5.12 during Thursday's after-market session. The market value of their outstanding shares is at $255.0 million.

Via Benzinga

Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting

September 22, 2022

From Spectrum Pharmaceuticals

Via Business Wire

With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma ↗

September 21, 2022

Via Benzinga

Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗

September 21, 2022

Gainers

Via Benzinga

Dow Dips 400 Points; Ford Shares Slide ↗

September 20, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 20, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.

Via Benzinga

Nasdaq Down 50 Points; Crude Oil Falls Sharply ↗

September 20, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.

Via Benzinga

Spectrum Plunges After FDA Casts Doubts On Its Lung Cancer Candidate ↗

September 20, 2022

Ahead of an adcomm meeting for Spectrum Pharmaceutical Inc (NASDAQ: SPPI), FDA released briefing documents related to poziotinib for treating patients with previously treated locally advanced or...

Via Benzinga

Looking Into Spectrum Pharmaceuticals's Recent Short Interest ↗

September 13, 2022

Spectrum Pharmaceuticals's (NASDAQ:SPPI) short percent of float has risen 14.81% since its last report. The company recently reported that it has 4.05 million shares sold short,...

Via Benzinga

What Is Going on With Spectrum Pharmaceuticals (SPPI) Stock Today? ↗

September 12, 2022

Spectrum Pharmaceuticals received regulatory approval for its oncology-related infection-reducing therapeutic, bolstering SPPI stock.

Via InvestorPlace

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Spectrum Pharmaceuticals: Here's What You Need To Know ↗

September 12, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Spectrum Pharmaceuticals (NASDAQ:SPPI) and raise its price target from $10.00 to $12.00. Shares of Spectrum Pharmaceuticals are trading up...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 12, 2022

Via Benzinga

Bristol-Myers Squibb, Carvana And Some Other Big Stocks Recording Gains In Today's Pre-Market Session ↗

September 12, 2022

U.S. stock futures traded higher this morning after recording gains in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 12, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.